Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Endonovo Therapeutics, Inc. (ENDV)

Total paid for Promotions this month: $5,000
E-mails this Month: 3
Estimated Volume Generated: $0
Research Report on ENDV: Click to see
* The information presented is based on information for Oct , 2015

Will This Pop Off The Open? Aug 07, 2015 09:23

  Get the Full Picture, View in a Browser Get New Picks Instantly. From Your Cell Phone Text the Word "TNBT" to 63566 Day 2, How High? Endonovo Therapeutics, Inc. (symbol: ENDV) The rumors were confirmed this morning...additional coverage is continuing to roll out into all corners of the investment community as other groups are jumping to cover ENDV. If you didn't believe us yesterday, you may want to start paying close ...read more
Promoter: TheNextBigTrade.com Paying Party: Emedia advisors
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 1.66 % Gain at close: Pending

More On The Way? Aug 07, 2015 09:18

  Get the Full Picture, View in a Browser Get Penny Stock News, Articles, Picks & Alerts Instantly. From Your Cell Phone Text the Word "BDPS" to 82257 Day 2, How High? Endonovo Therapeutics, Inc. (symbol: ENDV) The rumors were confirmed this morning...additional coverage is continuing to roll out into all corners of the investment community as other groups are jumping to cover ENDV. If you didn't believe us yesterday, ...read more
Promoter: BestDamnPennyStocks.com Paying Party: EMedia Solutions
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 1.66 % Gain at close: Pending

Reset That ENDV Trade Today Aug 07, 2015 08:05

Ride That Biotech Bounce! Rise Up, Traders! Biotech is tracking higher today in the pre-open, which means we got another shot at some fun on Endonovo Therapeutics Inc. (ENDV). Yeah, I know ENDV was YESTERDAY’s alert. But it ran in a circle when its big biotech brothers hit the brakes, so we didn’t get much joy. Now that the group is back on the gas pedal, today could give us the action ...read more
Promoter: Stock Commander Paying Party: Emerald Advisors
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $2,500 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
              ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Morning!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year growth, outperforming ...read more
Promoter: Prepump Stocks Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Morning!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed ...read more
Promoter: BeatPennyStocks Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                  ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Afternoon!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year ...read more
Promoter: PennyStock Buzz Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                 ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market Good Morning!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year growth, outperforming ...read more
Promoter: Penny Stock Newsletters Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                      ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Morning!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year ...read more
Promoter: DAMN GOOD PENNY PICKS Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
            ENDV On The Cusp Of Pre-clinical Testing In $24.5 Billion Liver Disease Market   Good Morning!   ENDV is a hot opportunity in a very developed and proven sector. I am talking about biotech, of course. In the last 10 years no other sector on Wall Street has been as consistent, or delivered as much gains.   Biotech has enjoyed year-to-year growth, outperforming every ...read more
Promoter: PENNY PICKS Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
          This Biotech Stock Is Set For Pre-Clinical Testing   Good Evening!   This stock has me super excited. Why? Because liver disease affects millions of people in the United States and this stock is already heading for pre-clinical testing.   My new alert features a company that is using non-invasive treatment through electroceutical technology to treat and reverse acute ...read more
Promoter: PENNY PICKS Paying Party: Microcap Innovations
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
First  << >> Last